Propanc Biopharma (PPCB) Total Liabilities (2011 - 2026)
Propanc Biopharma (PPCB) posted Total Liabilities of $3.38 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 41.0% from $5.73 million a year earlier.
Powered by 
Analysis
Propanc Biopharma (PPCB) Total Liabilities (2011 - 2026) Analysis & Trends
Since fiscal Q4 2011, Propanc Biopharma has reported Total Liabilities for 56 quarters.
- Annual Total Liabilities shows a five-year compound annual growth rate of 1.9% (FY2021 to FY2026).
- In prior fiscal years, Propanc Biopharma's Total Liabilities was $5.73 million in FY2025 (+48.7%), $3.85 million in FY2024 (+21.2%), $3.18 million in FY2023 (+2.3%) and $3.11 million in FY2022 (+0.8%).
- The fiscal Q4 2026 figure stands as the lowest quarterly Total Liabilities since fiscal Q1 2024.
- On a year-over-year basis, Total Liabilities increased in five of the last seven quarters, with growth averaging 9.4%.
- The strongest year-over-year quarter for Total Liabilities in the past five years was fiscal Q4 2025, with growth of 48.7%; the weakest was fiscal Q4 2026, with a decline of 41.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 87.82 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 65.46 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 83.95 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 37.53 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 115.64 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 7.18 Bn |
| 10 | Propanc Biopharma | 595,565.74 | 595,565.74 | - | 3.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.38 Mn |
| Dec 31, 2025 | 4.66 Mn |
| Sep 30, 2025 | 3.61 Mn |
| Jun 30, 2025 | 5.73 Mn |
| Mar 31, 2025 | 4.44 Mn |
| Dec 31, 2024 | 4.24 Mn |
| Sep 30, 2024 | 4.17 Mn |
| Jun 30, 2024 | 3.85 Mn |
| Mar 31, 2024 | 3.74 Mn |
| Dec 31, 2023 | 3.81 Mn |
| Sep 30, 2023 | 3.17 Mn |
| Jun 30, 2023 | 3.18 Mn |
| Mar 31, 2023 | 3.09 Mn |
| Dec 31, 2022 | 3.02 Mn |
| Sep 30, 2022 | 2.86 Mn |
| Jun 30, 2022 | 3.11 Mn |
| Mar 31, 2022 | 3.12 Mn |
| Dec 31, 2021 | 3.04 Mn |
| Sep 30, 2021 | 2.37 Mn |
| Jun 30, 2021 | 3.08 Mn |
API Access
Propanc Biopharma Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();